Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/02/2010WO2010138377A1 Compositions and methods for treating cancer
12/02/2010WO2010138184A2 Avian derived antibodies
12/02/2010WO2010138171A2 Methods for cancer treatment using stem cells
12/02/2010WO2010137890A2 Composition for improving the viability and proliferation ability of stem cells
12/02/2010WO2010137654A1 Pharmaceutical composition containing antagonist of egf family ligand as component
12/02/2010WO2010137295A1 Cdc45l peptides and vaccines including the same
12/02/2010WO2010137036A2 Novel japanese encephalitis vaccine and method of manufacturing the same
12/02/2010WO2010137020A1 Methods of treating inflammation
12/02/2010WO2010137017A2 Proteasome inhibitors and uses thereof
12/02/2010WO2010136947A1 Liposome based diepitope constructs
12/02/2010WO2010136897A2 Expression of recombinant proteins
12/02/2010WO2010136896A1 Assays for influenza virus hemagglutinins
12/02/2010WO2010136577A1 Stim2-mediated capacitive calcium entry
12/02/2010WO2010136569A1 Modulators for her2 signaling in her2 expressing patients with gastric cancer
12/02/2010WO2010136536A1 Anti-ck8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
12/02/2010WO2010136508A2 Stem cell targeting
12/02/2010WO2010136492A2 Antigen-binding proteins
12/02/2010WO2010136487A1 Albumin-amyloid peptide conjugates and uses thereof
12/02/2010WO2010136485A1 Antigen-binding proteins
12/02/2010WO2010136482A1 Antigen-binding proteins
12/02/2010WO2010136476A1 Extraneous agents testing
12/02/2010WO2010136443A1 Casb7439 constructs
12/02/2010WO2010136196A1 Immunoglobulin preparation for the treatment of autoimmune diseases and immune system disorders
12/02/2010WO2010136172A1 Tri- or tetraspecific antibodies
12/02/2010WO2010118324A3 Antibodies against fatty acid synthase
12/02/2010WO2010118203A3 Endosialin binding molecules
12/02/2010WO2010115843A3 Pharmaceutical composition
12/02/2010WO2010115278A8 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
12/02/2010WO2010111514A9 Rapid antemortem detection of infectious agents
12/02/2010WO2010111254A9 NOVEL ANTI-α5β1 ANTIBODIES AND USES THEREOF
12/02/2010WO2010097709A3 Polypeptides for the prevention or treatment of malaria
12/02/2010WO2010096678A3 Vesicular stomatitis virus vectors encoding hiv env epitopes
12/02/2010WO2010085588A3 Modulating angiogenesis
12/02/2010WO2010068923A3 Agents that selectively inhibit cd25 on dendritic cells or t cells and their use
12/02/2010WO2010064204A3 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
12/02/2010WO2000045847A8 Novel mucosal delivery system
12/02/2010US20100306863 Screening, therapy and diagnosis
12/02/2010US20100305151 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
12/02/2010US20100305048 Novel use of cytokine inhibitors
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100304368 Components and method for enzymatic synthesis of nucleic acids
12/02/2010US20100303918 Compositions and methods for treating asthma and other lung disorders
12/02/2010US20100303917 Compositions and methods for treating cystic fibrosis
12/02/2010US20100303901 Oral delivery of proteins and peptides
12/02/2010US20100303897 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
12/02/2010US20100303894 Pox viridae treatment
12/02/2010US20100303881 Therapeutic Electrospun Fiber Compositions
12/02/2010US20100303878 Biodegradable bioactive agent releasing matrices with particulates
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303868 Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
12/02/2010US20100303867 a composition comprising a notch ligand and an allergenb or allergen bystander antigen
12/02/2010US20100303866 Immunogenic peptides and their use in immune disorders
12/02/2010US20100303865 Use of oxazole derivatives for controlling fish parasites
12/02/2010US20100303864 Conserved and specific streptococcal genomes
12/02/2010US20100303863 Recombinant edwardsiella bacterium
12/02/2010US20100303862 Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
12/02/2010US20100303861 Live Attenuated Vaccine Strain for Prevention of Tularemia
12/02/2010US20100303860 Compositions and methods for administration of vaccines against dengue virus
12/02/2010US20100303859 Vectors and method for genetic immunization
12/02/2010US20100303858 Chimeric HIV-1 Glycoproteins and Their Biological Applications
12/02/2010US20100303857 Development of a preventive vaccine for filovirus infection in primates
12/02/2010US20100303856 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/02/2010US20100303852 Conjugation process for pnag and a carrier protein
12/02/2010US20100303851 Immunostimulation by chemically modified rna
12/02/2010US20100303850 Nanocarriers possessing components with different rates of release
12/02/2010US20100303849 Lipidated Vaccine against Dengue Virus Infection
12/02/2010US20100303848 Vaccination method
12/02/2010US20100303847 Compositions of toll-like receptor agonists and papillomavirus antigens and methods of use thereof
12/02/2010US20100303846 Immunostimulatory Nucleic Acid Packaged Particles for the Treatment of Hypersensitivity
12/02/2010US20100303845 Novel gene expressed in prostate cancer
12/02/2010US20100303844 Modification of intrinsically disordered sequences for the preparation of vaccines
12/02/2010US20100303843 RECOMBINANT ALLERGEN WITH REDUCED lgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
12/02/2010US20100303842 Peptide analogues
12/02/2010US20100303841 Adjuvant
12/02/2010US20100303840 Use of creatine or creatine analogs for the treatment of diseases of the nervous system
12/02/2010US20100303839 Methods and compositions for treatment of cancer using oncolytic rsv activity
12/02/2010US20100303838 Vectors for multiple gene expression
12/02/2010US20100303837 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
12/02/2010US20100303836 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
12/02/2010US20100303835 Peptoid ligands for isolation and treatment of autoimmune t-cells
12/02/2010US20100303834 Compositions and methods for the diagnosis and treatment of tumor
12/02/2010US20100303833 Method for Identifying a MHC Class H-Dependent Tumor Associated T Helper Cell Antigen
12/02/2010US20100303832 Genes and polymorphisms associated with amd
12/02/2010US20100303831 Methods For The Treatment Of An Infectious Bacterial Disease With An Anti-Lactone Or Lactone Derived Signal Molecules Antibody
12/02/2010US20100303830 PREVENTION AND TREATMENT OF OTITIS MEDIA USING IgA ENRICHED MILK
12/02/2010US20100303829 Hiv vpr-specific t cell receptors
12/02/2010US20100303828 Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells Activity
12/02/2010US20100303827 Protein Formulation
12/02/2010US20100303826 Use of ADCC-Optimized antibodies for treating weak patients
12/02/2010US20100303825 Anti-estrogen and immune modulator combinations for treating breast cancer
12/02/2010US20100303824 Signaling intermediates in an in vitro model of alzheimer's disease
12/02/2010US20100303823 Human monoclonal antibodies against interleukin 8 (il-8)
12/02/2010US20100303822 Polypeptides from non-typeable haemophilus influenzae
12/02/2010US20100303821 Immunoglobulins
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303819 Dcl-1 and uses thereof
12/02/2010US20100303818 Dendritic cell receptor
12/02/2010US20100303817 Antibodies to treat cancer
12/02/2010US20100303816 Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (mcsp)
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 1823